-

‘Being a decent person is foundation for lasting success’: outgoing InterDigital IP head
Read more: ‘Being a decent person is foundation for lasting success’: outgoing InterDigital IP headFollowing her departure from InterDigital last month, Mang Zhu sits down with ip fray to reflect on her time as Head of IP, discuss what’s next for her, and share what she’d tell younger women aspiring to get to her position following her decades-long career in SEP licensing.
-
Supercomputer firm ParTec files another Unified Patent Court lawsuit against NVIDIA, seeking 18-country injunction
Read more: Supercomputer firm ParTec files another Unified Patent Court lawsuit against NVIDIA, seeking 18-country injunctionSupercomputer firm ParTec ups the pressure on NVIDIA (and, by extension, Microsoft) by asserting a recently granted unitary patent in the Unified Patent Court.
-
UPC Roundup (1 week): stay pending appeal granted over defendant’s objection; various cost-related decisions and one about unitary effect
Read more: UPC Roundup (1 week): stay pending appeal granted over defendant’s objection; various cost-related decisions and one about unitary effectThis is a summary of developments in and around the Unified Patent Court (UPC) in the week since our August 3, 2025 UPC Roundup. 1. Dusseldorf LD 1.1 Injunction by default judgment (igus v. Whale Technology) (link to LinkedIn post) The Dusseldorf Local Division (LD) has issued a default judgement against Whale Technology (PDF in German),…
-
Netflix countersuit against Broadcom thrown out as patent claims deemed abstract, amendment allowed but not necessarily helpful
Read more: Netflix countersuit against Broadcom thrown out as patent claims deemed abstract, amendment allowed but not necessarily helpfulA strict application of § 101 resulted in the dismissal of one of Netflix’s coutnersuits against Broadcom. An amended complaint would be entertained, though.
-
The Trump Administration is not above the law — but neither is Harvard: patent march-in rights
Read more: The Trump Administration is not above the law — but neither is Harvard: patent march-in rightsWhatever allegations the Trump Administration makes against Harvard and its affiliates may ultimately have to be discussed in court. But Harvard’s compliance is not beyond doubt.
-
BREAKING: GSK cashes in on license deal as CureVac settles U.S. patent dispute with acquirer BioNTech and Pfizer for $790M+
Read more: BREAKING: GSK cashes in on license deal as CureVac settles U.S. patent dispute with acquirer BioNTech and Pfizer for $790M+Pfizer and BioNTech have settled their three-year COVID vaccine-related patent infringement dispute with CureVac in the U.S., granting the latter and its licensing partner GSK $370 million each.
-
NPEs file as few as 10% of ITC Section 337 complaints: agency counsel
Read more: NPEs file as few as 10% of ITC Section 337 complaints: agency counselBetween 70% and 90% of ITC investigations are initiated by non-NPEs, with those numbers generally increasing, while there is a notable shift in the NPEs that do file complaints toward being more innovation-focused.
-
Chinese court enforces $73 million U.S. judgment: door opens for more foreign order enforceability, including UPC
Read more: Chinese court enforces $73 million U.S. judgment: door opens for more foreign order enforceability, including UPCA Chinese order enforcing a U.S. judgment based on reciprocity could mean the Unified Patent Court will no longer require Chinese companies to pay collateral, with the increased possibility that UPC judgments will now be enforced in China too.


